We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

151 hedge funds and large institutions have $396M invested in Sciclone Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $210K | Put options by funds: $136K

35% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 46

0% more funds holding

Funds holding: 151151 (0)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

24% less capital invested

Capital invested by funds: $521M → $396M (-$124M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
151
Holders Change
Holders Change %
0%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
22
Increased
62
Reduced
46
Closed
22
Calls
$210K
Puts
$136K
Net Calls
+$74K
Net Calls Change
-$1.21M
Name Holding Trade Value Shares
Change
Change in
Stake
RIM
51
Ranger Investment Management
Texas
$1.11M +$90.3K +8,290 +8%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$1.08M +$7.63K +700 +0.7%
AA
53
ALPS Advisors
Colorado
$1.07M -$102K -9,384 -8%
PPA
54
Parametric Portfolio Associates
Washington
$1.02M -$265K -24,351 -20%
HHC
55
Hutchin Hill Capital
New York
$935K +$31.6K +2,900 +3%
Barclays
56
Barclays
United Kingdom
$897K -$43.2K -3,965 -4%
BG
57
BlackRock Group
United Kingdom
$887K +$35.8K +3,289 +4%
EA
58
Emerald Acquisition
Washington
$873K +$278K +25,527 +43%
Swiss National Bank
59
Swiss National Bank
Switzerland
$836K -$53.4K -4,900 -6%
Allianz Asset Management
60
Allianz Asset Management
Germany
$834K +$900K +82,652 New
AI
61
Analytic Investors
California
$803K +$853K +78,322 New
TA
62
Teachers Advisors
New York
$801K
CIP
63
Convergence Investment Partners
Florida
$788K +$838K +76,895 New
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$731K +$83.9K +7,700 +12%
Canada Life
65
Canada Life
Manitoba, Canada
$698K +$34.8K +3,197 +5%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$671K +$31.9K +2,930 +5%
Asset Management One
67
Asset Management One
Japan
$651K
ZCM
68
Zebra Capital Management
Connecticut
$645K +$106K +9,726 +18%
EGA
69
Eagle Global Advisors
Texas
$629K
CS
70
Credit Suisse
Switzerland
$588K -$652K -59,823 -51%
SO
71
STRS Ohio
Ohio
$564K -$22.9K -2,100 -4%
Comerica Bank
72
Comerica Bank
Texas
$521K +$8.29K +761 +2%
PP
73
PDT Partners
New York
$509K +$26.1K +2,400 +5%
Citigroup
74
Citigroup
New York
$506K +$235K +21,549 +77%
MERSOM
75
Municipal Employees' Retirement System of Michigan
Michigan
$483K +$1.31K +120 +0.3%

SCLN Hedge Fund Activity: Q3 2016 in Review

151 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2016, worth a combined $396M — down 24% from $521M a quarter earlier.

Fund positioning in SCLN was balanced in Q3 2016: 22 funds opened new positions, 22 closed out, 62 added to existing stakes and 46 trimmed.

The largest buyer was Numeric Investors, adding an estimated $22.7M. The largest seller was Franklin Resources, cutting an estimated $35.4M.

  • 151 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $396M of Sciclone Pharmaceuticals Inc stock for Q3 2016, down 24% quarter-over-quarter.
  • 22 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2016 and 22 closed out, a net change of 0 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q3 2016 was Numeric Investors, an estimated $22.7M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q3 2016 was Franklin Resources, an estimated $35.4M sold.

Based on aggregated 13F filings for Q3 2016.